Evidence map›Paper›PMID 34592042›Full record

ArticleHaemophilia : the official journal of the World Federation of Hemophilia2021

Perceptions about the efficacy of extended half-life (EHL) factor products in persons with haemophilia (PWH): A national survey of haemophilia providers from haemophilia treatment centres (HTCs) in the United States.

Neeraja Swaminathan, Vanessa Salinas-Luna, Suchitra Acharya, Anjali Sharathkumar

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haemophilia : the official journal of the World Federation of Hemophilia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Neeraja SwaminathanDivision of Pediatric Hematology Oncology, Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID https://orcid.org/0000-0002-6824-4883
Vanessa Salinas-LunaCenter for Inherited Blood Disorders, Orange, California, USA.
Suchitra AcharyaDivision of Pediatric Hematology Oncology, Department of Pediatrics, Northwell Health, New Hyde Park, New York, USA.
Anjali SharathkumarDivision of Pediatric Hematology Oncology, Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID https://orcid.org/0000-0003-4574-6175
University of Iowa · USCenter for Inherited Blood Disorders · USNorthwell Health · US

Funding

PROGRAM IN HEMOSTASIS AND THROMBOSIS FOR ACADEMICT32HL007344 · NHLBI · UNIVERSITY OF IOWA · PI Anil Kumar Chauhan, Steven R Lentz · 1985 to 2026
$6.5M
NHLBI NIH HHS T32 HL007344
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hemophilia AHemophilia BFactor VIIIHalf-LifeHumansUnited StatesFactor VIIIextended half-life factor concentrates (EHLs)factor switchinghaemophiliastandard half-life factor concentrates (SHLs)

Identifiers

PMID34592042
PMCPMC11984519
OpenAlexW3202468395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.